Comprehensive labs
Quest, LabCorp, and CLIA panels to anchor your data-first approach.
Who it's for
Labs, protocols, and supplements that fit a data-driven model
Your patients already expect deep diagnostics and a personalized plan. Wellstaq gives you branded labs, a genetic pathway report, provider-evaluated categories like peptides, and your own supplement line on one platform.
Built for how you already practice
Functional and integrative practices run on data: comprehensive panels, root-cause work, and protocols tailored to the individual. Wellstaq packages that into a branded experience where peptides and other categories are provider-evaluated rather than self-selected. Patients intake, an independent provider reviews the full picture, and any prescribing sits with the licensed network.
14 pathways in the branded genetic report
What you can offer under your brand
Genetic pathway report
An educational report mapping variants to pathways as a roadmap to discuss with a provider.
Provider-evaluated categories
Peptide, longevity, and hormone categories evaluated by the licensed network, never pre-recommended.
Your own supplement line
A branded supplement line on shared infrastructure, priced by you.
How it works for you
-
01
Patients intake under your brand
Branded intake captures history and goals before any clinical step.
-
02
A network provider evaluates
An independent provider licensed in their state reviews labs and intake and owns any prescribing.
-
03
You build the program and set retail
Labs and supplements come in at wholesale; you set retail and keep the margin, Wellstaq takes 0%.
How the economics work
One flat fee. Everything else at wholesale.
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
Programs that fit
Frequently asked questions
Can I offer peptide programs?
Peptide categories are provider-evaluated. An independent licensed provider decides whether they are appropriate and owns any prescribing, where the regulatory pathway permits. Nothing is recommended before that evaluation.
Is the genetic report diagnostic?
No. It is an educational pathway report meant as a roadmap to discuss with a provider; it does not diagnose or determine which products anyone should use.
Bring your data-driven model under one brand
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.